Clinical Trials Browser

Phase 1/2 × OTHER_GOV × Immune Checkpoint Inhibitors × Clear all

NCT05937438 2025-01-29

Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma

Phase 1/2 Recruiting

Gastrointestinal

Esophageal Neoplasms